InspireMD, Inc.
NSPR
$2.46
-$0.015-0.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.78% | -21.71% | -16.27% | 0.24% | -12.47% |
| Total Depreciation and Amortization | 9.18% | 30.67% | 7.14% | 6.06% | -4.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.22% | 39.89% | -5.93% | -14.71% | 2.03% |
| Change in Net Operating Assets | 329.81% | -260.71% | 1,780.00% | -102.04% | 275.00% |
| Cash from Operations | 5.22% | -30.25% | -18.42% | -30.91% | 14.02% |
| Capital Expenditure | -60.45% | -15.43% | 26.13% | 11.37% | -143.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 186.17% | -75.90% | 255.42% | -192.01% | 19.33% |
| Cash from Investing | 212.69% | -79.35% | 239.13% | -207.59% | 14.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 304.73% | -67.88% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 72.84% | -- | -- | -- |
| Cash from Financing | 322.33% | -67.63% | 261.97% | -105.40% | -- |
| Foreign Exchange rate Adjustments | -100.00% | 18.60% | 95.45% | 320.00% | -150.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 86.62% | -310.88% | 124.65% | -166.16% | 7,668.13% |